Skip to main content
. 2023 Mar 31;33(5):1564–1570. doi: 10.1007/s11695-023-06561-y

Table 1.

Baseline characteristics

Entire group except controls RYGB SG BPD/DS Control group
Number of patients 58,366 51,152 6781 433 583,660
Age 41.0 ± 11.1 40.9 ± 11.2 41.2 ± 10.7 37.8 ± 10.8 41.0 ± 11.1
BMI 42.0 ± 5.68 42.3 ± 5.42 39.4 ± 5.70 56.5 ± 6.78 Unknown
Sex
 Women 44,459 (76.2%) 38,719 (75.7%) 5488 (80.9%) 252 (58.2%) 444,590 (76.2%)
 Men 13,907 (23.8%) 12,433 (24.3%) 1293 (19.1%) 181 (41.8%) 139,070 (23.8%)
Comorbidity
 Hypertension 14,459 (19.4%) 13,012 (25.4%) 1316 (19.4%) 131 (30.3%) 51,134 (8.8%)
 Type 2 diabetes 7978 (13.7%) 7323 (14.3%) 577 (8.5%) 78 (18.0%) 13,120 (2.2%)
 Dyslipidemia 5558 (9.5%) 5053 (9.9%) 461 (6.8%) 44 (10.2%) 24,457 (3.7%)
 Depression 8788 (15.1%) 7582 (14.8%) 1132 (16.7%) 74 (17.1%) 67,029 (11.5%)
 Sleep apnea 5650 (9.7%) 5103 (10.0%) 435 (6.4%) 112 (25.9%) Unknown
 Previous kidney stones 190 (0.3%) 175 (0.3%) 11 (0.2%) 4 (0.9%) 543 (0.1%)

RYGB = Roux-en-Y gastric bypass; SG = sleeve gastrectomy; BPD/DS = biliopancreatic diversion with duodenal switch

Data on BMI and sleep apnea could not be obtained for the control group; otherwise, there were no missing data for any of the baseline characteristics